BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9437789)

  • 1. Definition of the potentially fertile period from urinary steroid excretion rates. Part II. A threshold value for pregnanediol glucuronide as a marker for the end of the potentially fertile period in the human menstrual cycle.
    Blackwell LF; Brown JB; Cooke D
    Steroids; 1998 Jan; 63(1):5-13. PubMed ID: 9437789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of ovarian activity by measurement of urinary excretion rates using the Ovarian Monitor, Part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period.
    Blackwell LF; Vigil P; Alliende ME; Brown S; Festin M; Cooke DG
    Hum Reprod; 2016 Feb; 31(2):445-53. PubMed ID: 26677961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
    Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
    Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The measurement of urinary steroid glucuronides as indices of the fertile period in women. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, special programme of research, development and research training in human reproduction.
    Adlercreutz H; Brown J; Collins W; Goebelsman U; Kellie A; Campbell H; Spieler J; Braissand G
    J Steroid Biochem; 1982 Dec; 17(6):695-702. PubMed ID: 7176659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the Home Ovarian Monitor in pregnancy avoidance.
    Brown JB; Holmes J; Barker G
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing.
    Blackwell LF; Vigil P; Gross B; d'Arcangues C; Cooke DG; Brown JB
    Hum Reprod; 2012 Feb; 27(2):550-7. PubMed ID: 22131389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
    Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
    Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL; Sweeting VM; Hillier H; Baird DT
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.
    Roos J; Johnson S; Weddell S; Godehardt E; Schiffner J; Freundl G; Gnoth C
    Eur J Contracept Reprod Health Care; 2015; 20(6):438-50. PubMed ID: 26018113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The validation of the Billings ovulation method by laboratory research and field trials.
    Billings JJ
    Acta Eur Fertil; 1991; 22(1):9-15. PubMed ID: 1746210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct measurement of pregnanediol 3-glucuronide (PDG) in dried urine spots by liquid chromatography-mass spectrometry to detect ovulation.
    Handelsman DJ; Nimmagadda R; Desai R; Handelsman TD; Whittle B; Skorupskaite K; Anderson RA
    J Steroid Biochem Mol Biol; 2021 Jul; 211():105900. PubMed ID: 33872762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptothermal and hormonal markers of potential fertility in climacteric women.
    Flynn AM; James P; Collins WP; Royston P
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):1987-9. PubMed ID: 1755454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal monitoring of ovarian activity using the Ovarian Monitor, part I. Validation of home and laboratory results obtained during ovulatory cycles by comparison with radioimmunoassay.
    Blackwell LF; Brown JB; Vigil P; Gross B; Sufi S; d'Arcangues C
    Steroids; 2003 May; 68(5):465-76. PubMed ID: 12798498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of daily consumption of milk powder on menstrual cycles and urine sex hormone concentrations of young women].
    Zhang M; Ju J; Wang Z; Wu J; Geng S; Liu J; Yang Y
    Wei Sheng Yan Jiu; 2014 Sep; 43(5):754-8. PubMed ID: 25438529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring ovarian cycle activity via progestagens in urine and feces of female mountain gorillas: A comparison of EIA and LC-MS measurements.
    Habumuremyi S; Robbins MM; Fawcett KA; Deschner T
    Am J Primatol; 2014 Feb; 76(2):180-91. PubMed ID: 24123105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective multicentre study to develop universal immunochemical tests for predicting the fertile period in women. World Health Organisation Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
    Int J Fertil; 1985; 30(3):18-30. PubMed ID: 2867054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of pregnanetriol in the menstrual cycle. II. Concurrent assay of other urinary steroids in ovulatory cycles.
    PICKETT MT; SOMMERVILLE IF
    Acta Endocrinol (Copenh); 1962 Sep; 41():135-42. PubMed ID: 14486396
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
    Stanczyk FZ; Miyakawa I; Goebelsmann U
    Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary progesterone and pregnanediol. Use for monitoring progesterone treatment.
    Stanczyk FZ; Gentzschein E; Ary BA; Kojima T; Ziogas A; Lobo RA
    J Reprod Med; 1997 Apr; 42(4):216-22. PubMed ID: 9131494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Descriptive analysis of the relationship between progesterone and basal body temperature across the menstrual cycle.
    Écochard R; Leiva R; Bouchard T; Boehringer H; Iwaz J; Plotton I
    Steroids; 2022 Feb; 178():108964. PubMed ID: 35065994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.